| Having trouble reading this newsletter? Click here to see it in your browser. You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe. |
 11 May 2010  |
 |
|
Dealmakers Update - May 2010Sponsored this month by: BioPharm America 2010 BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring®. Visit BioPharm America for details.
Editor's cornerThis special edition of Dealmakers newsletter provides a review of the bus dev elements of BIO2010 last week in Chicago. Nearly 15,000 delegates attended the event, with over 2,000 delegates from 2,000+ companies participating in the Business Forum, resulting in an excess of 17,000 scheduled one to one meetings. Currentpartnering has provided a series of BIO2010 reviews: - The bigpharma paradigm shift to out-licensing More to follow in the coming week - look out for our Dealmakers Roundup towards the end of the month. If you can't wait until the end of the month, we have upped our presence on LinkedIn and Twitter, so to keep up to the minute on the latest partnering developments, join now. An interesting new product launched at BIO2010 was a free to post online partnering database. This new service appears to provide a fresh approach to seeking partners online - view Qualoria. Enjoy the brief respite before the next major partnering event - Euromedtech in early June. For a list of additional events don't forget to visit our Partnering Events diary regularly. All for now. -- Steve Poile -- Scorecard updateUpdated today - May 11, 2010 Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index. Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month. In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard. Latest update! Bigpharma partnering activity 2006 to present - view details here In the newsThe following are just some of the deals involving bigpharma announced in the last few weeks: Deals of note so far in May 2010:
Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature. Signup for our updates via LinkedIn and Twitter. Partnering roundupJust some of the articles picked up by Roundup during early April:
Signup for our updates via LinkedIn and Twitter. Best practiceBest practise for dealmakers by dealmakers. Current Partnering seeks out the best articles from various sources, to keep you updated on partnering best practice. BIO2010 Review: How to acquire new products and technologies A review of the BIO2010 breakout session on partnering trends more BIO2010 Review: Regional dealmaking comes into focus Regional dealmaking is beccoming increasingly common even if its simply surrendering co-promote options to the licensor. However there are many other reasons why regional deals should bee considered more BIO2010 Review: The bigpharma paradigm shift to out-licensing Not so long ago bigpharma would not consider out-licensing redundant assets and bus dev personnel would not even entertain such thoughts - all change now more Patents for life The role of intellectual property rights on plant innovations more New and updated reportsRecently updated reports: Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 3rd edition The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 3rd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 3rd edition The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 3rd edition. Partnering Agreements with Bigpharma The definitive guide to bigpharma partnering interests, contacts & agreements Distribution Agreements in Pharma, Biotech and Diagnostics, 2nd edition Provides comprehensive understanding and unprecedented access to the distribution agreements entered into by the worlds leading pharma, biotech and diagnostics companies New report titles: CurrentPartnering has published new titles: Drug Delivery Partnering Agreements in Pharma, Biotech and Diagnostics Provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading companies • Comprehensive directory of drug delivery deals since 2003 Partnering Agreements in Diagnostics Providing detailed understanding and analysis of how and why companies enter diagnostic partnering deals, plus access to actual diagnostic agreements Oncology Partnering Agreements in Pharma, Biotech and Diagnostics The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies • Comprehensive directory of oncology deals since 2003 Option & Evaluation Agreements in Pharma and Biotech The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies Royalty Financing Agreements in Pharma, Biotech and Diagnostics The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals. Forthcoming partnering eventsHere are some of our suggested events for summer/fall 2010: Annual C21 Bioventures 2010 Napa, CA, USA - May 25-27, 2010 - more details EuroMedtech 2010 Leipzig, Germany - June 1-2, 2010 - more details BioPartnering India 2010 Bangalore, India - June 2-4, 2010 - more details ERBI Conference 2010 Cambridge, United Kingdom - June 2-3, 2010 - more details EuroPLX 43 Berlin Berlin, Germany - June 14-15, 2010 - more details ChinaBio Partnering Forum 2010 Suzhou, China - June 23-24, 2010 - more details Euro-Biotech Forum 2010 Paris, France - June 28-30, 2010 - more details BioPharm America 2010 Boston, MA, USA - September 15-17, 2010 - more details People on the moveThe following people have been reported on the move during May 2010: Thomas Pitler, Neil Larimer, Michael Miller to name just a few read more about the latest people on the move. If you have news about a business development executive who is on the move - let us know Partnering resourcesCurrent Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries. The following topic areas are available - updated regularly: • Partnering organizations Advertizing and sponsorshipCurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online. or contact us to discuss your requirements. Contact usSteve Poile, Editor Web: http://www.CurrentPartnering.com Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom Tel: +44 7896 656732 Fax: +44 8703 305993 About CurrentpartneringCurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers • Reports |
|
|
|
Sponsored by: 
CurrentPartnering reports
|
|
|
||
|
 |
|